Skip to main content Accessibility help
×
Home
Hostname: page-component-cf9d5c678-dksz7 Total loading time: 0.149 Render date: 2021-08-01T02:35:49.456Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Article contents

FC31-02 - Is it ethical not to prescribe placebo? the patient's perspective on the usage of placebo for the treatment of depression - a comparative study

Published online by Cambridge University Press:  16 April 2020

K. Feffer
Affiliation:
Outpatient Clinic, Shalvata Mental Health Center, Hod-Hashron, Jerusalem
U. Nitzan
Affiliation:
Outpatient Clinic, Shalvata Mental Health Center, Hod-Hashron, Jerusalem
P. Lichtenberg
Affiliation:
Men - Department, Herzog Hospital, Jerusalem Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem
S. Lev-Ran
Affiliation:
Outpatient Clinic, Shalvata Mental Health Center, Hod-Hashron, Jerusalem Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel
S. Fennig
Affiliation:
Outpatient Clinic, Shalvata Mental Health Center, Hod-Hashron, Jerusalem Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel
Get access

Abstract

Introduction

The current stands of the medical establishment exclude usage of placebo in the clinical setting on ethical grounds. No attempt has been made to clarify the viewpoint of the psychiatric patient regarding the matter.

Objective

To compare the viewpoint of healthy subjects to that of patients who suffered from depressive episode.

Aims

  1. 1) Investigate the willingness of subjects in both groups to receive placebo for the treatment of depression, and

  2. 2) compare both groups’ views regarding the ethical aspect of placebo usage (e.g. doctor-patient relationship, patient's autonomy, etc).

Method

We enrolled 81 patients and 107 healthy subjects. Patients were recruited from an out-patient clinic and were diagnosed, in the past or present, as suffering from a depressive episode. All subjects were briefed thoroughly about the efficacy, potential benefits and limitations of placebo in treating depression and then completed a self-report questionnaire.

Results

64% of the patients (N = 50) expressed consent to use placebo in case they suffer again from depressive symptoms, compared to 79% (N = 85) of healthy subjects (p< 0.05). In both groups over 70% of the subjects do not perceive prescribing placebo as a deceit or as an act that diminishes the patients' autonomy (p>0.05).

Conclusions

The majority of patients agreed to receive placebo medication as a first line treatment, and do not feel that it will negatively affect their sense of autonomy or doctor-patient relationship. These findings question some of the ethical justification of excluding placebo from the clinical practice and call for further discussion in the subject.

Type
Research Article
Copyright
Copyright © European Psychiatric Association 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Submit a response

Comments

No Comments have been published for this article.
1
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

FC31-02 - Is it ethical not to prescribe placebo? the patient's perspective on the usage of placebo for the treatment of depression - a comparative study
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

FC31-02 - Is it ethical not to prescribe placebo? the patient's perspective on the usage of placebo for the treatment of depression - a comparative study
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

FC31-02 - Is it ethical not to prescribe placebo? the patient's perspective on the usage of placebo for the treatment of depression - a comparative study
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *